Autonomix Medical (NASDAQ:AMIX) Issues Earnings Results, Beats Expectations By $1.38 EPS

Autonomix Medical (NASDAQ:AMIX) issued its quarterly earnings data on Wednesday. The company reported ($5.02) EPS for the quarter, beating analysts’ consensus estimates of ($6.40) by $1.38, FiscalAI reports.

Autonomix Medical Stock Down 8.2%

Shares of NASDAQ:AMIX traded down $0.62 during midday trading on Thursday, reaching $6.91. The company’s stock had a trading volume of 257,372 shares, compared to its average volume of 1,562,435. The firm has a market cap of $6.70 million, a price-to-earnings ratio of -0.09 and a beta of -1.17. Autonomix Medical has a 1 year low of $2.44 and a 1 year high of $32.55. The business has a 50 day moving average price of $6.86 and a 200 day moving average price of $7.76.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the stock. Zacks Research raised shares of Autonomix Medical to a “hold” rating in a research note on Tuesday, June 2nd. Weiss Ratings raised Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a research note on Tuesday, July 28th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Autonomix Medical presently has an average rating of “Hold” and a consensus target price of $42.00.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.